Bengt Erik Dahlström

Board of Directors, PMC Clinical Research Aktiebolag

Sveavägen 8SE10 active roles

Bengt Erik Dahlström is a Swedish director with 10 active roles across Swedish companies, including Board of Directors at PMC Clinical Research Aktiebolag.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

in directorship history

Career timeline

2025 – now
Deputy Board Member, RegFile AB
2024 – 2026
Board of Directors, Zelmic AB
2023 – now
Board of Directors, PMC Clinical Research Aktiebolag
2023 – now
Board of Directors, PMC Analytical Services Aktiebolag
2023 – now
Board of Directors, PMC Drug Study Unit Aktiebolag
2023 – now
Board of Directors, UppInvest in Sweden AB
2023 – now
Board of Directors, QAlliance AB
2022 – now
Board of Directors, Epimeleia AB
2022 – now
Board of Directors, UppuCare AB
2022 – 2026
Board of Directors, CTC Clinical Trial Consultants AB
2022 – 2026
Board of Directors, RegSmart Life Science AB
2022 – 2026
Board of Directors, Lablytica Life Science AB
2022 – 2025
Board of Directors, CTR Translational Next AB
2022 – 2022
Board of Directors, Metasafe Sweden AB
2021 – now
Board of Directors, Aktiebolaget Biopharmacon
2021 – now
Board of Directors, Center for Translational Research Sweden AB
2020 – 2026
Board of Directors, Toxicology Knowledge Team Sweden AB

Personal details

Nationality

Address

Sveavägen 8

Bengt Erik Dahlström

Overview

Career timeline

Personal details

More on Bengt Erik Dahlström

Overview

Career timeline

Personal details

More on Bengt Erik Dahlström